These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 28975099

  • 1. Predictive risk factors of steroid dependent nephrotic syndrome in children.
    Abdel-Hafez MA, Abou-El-Hana NM, Erfan AA, El-Gamasy M, Abdel-Nabi H.
    J Nephropathol; 2017 Jul; 6(3):180-186. PubMed ID: 28975099
    [Abstract] [Full Text] [Related]

  • 2. [Idiopathic nephrotic syndrome in children: Incidence, clinical presentation, and outcome in the county of Gironde, France].
    Ernould S, Godron A, Nelson JR, Rigothier C, Llanas B, Harambat J.
    Arch Pediatr; 2011 May; 18(5):522-8. PubMed ID: 21458969
    [Abstract] [Full Text] [Related]

  • 3. Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome.
    Mohamad K, Zainal H, Abdul Rahim NA, Tengku Hussain TH.
    J Nephrol; 2024 Sep 01. PubMed ID: 39218996
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for steroid dependency in children with idiopathic nephrotic syndrome.
    Yap HK, Han EJ, Heng CK, Gong WK.
    Pediatr Nephrol; 2001 Dec 01; 16(12):1049-52. PubMed ID: 11793098
    [Abstract] [Full Text] [Related]

  • 5. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N, Kim S, Craig J, Hodson E.
    Arch Dis Child; 2016 Apr 01; 101(4):404-8. PubMed ID: 26289063
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome.
    Mantan M, Kansal A, Swarnim S.
    Indian J Nephrol; 2022 Apr 01; 32(6):588-594. PubMed ID: 36704589
    [Abstract] [Full Text] [Related]

  • 7. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2004 Apr 01; (2):CD001533. PubMed ID: 15106158
    [Abstract] [Full Text] [Related]

  • 8. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2003 Apr 01; (1):CD001533. PubMed ID: 12535410
    [Abstract] [Full Text] [Related]

  • 9. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
    [Abstract] [Full Text] [Related]

  • 10. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 11. [Childhood steroid-dependent idiopathic nephrotic syndrome: Predictive factors for the need of immunosuppressive treatment].
    Golay M, Douillard A, Nagot N, Fila M, Ichay L, Dalla Vale F, Tenenbaum J, Morin D.
    Arch Pediatr; 2017 Nov 01; 24(11):1096-1102. PubMed ID: 28941627
    [Abstract] [Full Text] [Related]

  • 12. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.
    Kemper MJ, Valentin L, van Husen M.
    Pediatr Nephrol; 2018 Oct 01; 33(10):1641-1649. PubMed ID: 28879428
    [Abstract] [Full Text] [Related]

  • 13. Childhood Idiopathic Nephrotic Syndrome: Does the Initial Steroid Treatment Modify the Outcome? A Multicentre, Prospective Cohort Study.
    Pasini A, Bertulli C, Casadio L, Corrado C, Edefonti A, Ghiggeri G, Ghio L, Giordano M, La Scola C, Malaventura C, Maringhini S, Mastrangelo AP, Materassi M, Mencarelli F, Messina G, Monti E, Morello W, Puccio G, Romagnani P, Montini G, NefroKid Study Group.
    Front Pediatr; 2021 Oct 01; 9():627636. PubMed ID: 34307246
    [Abstract] [Full Text] [Related]

  • 14. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar 01; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 15. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.
    Iijima K, Sako M, Kamei K, Nozu K.
    Pediatr Nephrol; 2018 Sep 01; 33(9):1449-1455. PubMed ID: 28717938
    [Abstract] [Full Text] [Related]

  • 16. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct 01; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study of the conventional scheme and prolonged treatment with steroids on primary steroid-sensitive nephrotic syndrome in children].
    Liern M, Codianni P, Vallejo G.
    Bol Med Hosp Infant Mex; 2016 Oct 01; 73(5):309-317. PubMed ID: 29384123
    [Abstract] [Full Text] [Related]

  • 18. Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses?
    Göknar N, Webb H, Waters A, Tullus K.
    Pediatr Nephrol; 2022 Jul 01; 37(7):1575-1584. PubMed ID: 34767076
    [Abstract] [Full Text] [Related]

  • 19. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
    Veltkamp F, Khan DH, Reefman C, Veissi S, van Oers HA, Levtchenko E, Mathôt RAA, Florquin S, van Wijk JAE, Schreuder MF, Haverman L, Bouts AHM.
    BMJ Open; 2019 Aug 01; 9(8):e027011. PubMed ID: 31375606
    [Abstract] [Full Text] [Related]

  • 20. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K, Parikh A, Webb H, Hothi D.
    Pediatr Nephrol; 2017 Jan 01; 32(1):99-105. PubMed ID: 27677978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.